1. Home
  2. CUE vs NEON Comparison

CUE vs NEON Comparison

Compare CUE & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • NEON
  • Stock Information
  • Founded
  • CUE 2014
  • NEON 1997
  • Country
  • CUE United States
  • NEON Sweden
  • Employees
  • CUE N/A
  • NEON N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • NEON Industrial Machinery/Components
  • Sector
  • CUE Health Care
  • NEON Technology
  • Exchange
  • CUE Nasdaq
  • NEON Nasdaq
  • Market Cap
  • CUE 61.1M
  • NEON 56.4M
  • IPO Year
  • CUE 2018
  • NEON 2007
  • Fundamental
  • Price
  • CUE $0.70
  • NEON $3.05
  • Analyst Decision
  • CUE Strong Buy
  • NEON Hold
  • Analyst Count
  • CUE 2
  • NEON 1
  • Target Price
  • CUE $3.00
  • NEON $6.00
  • AVG Volume (30 Days)
  • CUE 270.3K
  • NEON 421.4K
  • Earning Date
  • CUE 11-12-2025
  • NEON 11-05-2025
  • Dividend Yield
  • CUE N/A
  • NEON N/A
  • EPS Growth
  • CUE N/A
  • NEON N/A
  • EPS
  • CUE N/A
  • NEON N/A
  • Revenue
  • CUE $8,286,000.00
  • NEON $2,605,000.00
  • Revenue This Year
  • CUE N/A
  • NEON N/A
  • Revenue Next Year
  • CUE N/A
  • NEON $43.34
  • P/E Ratio
  • CUE N/A
  • NEON N/A
  • Revenue Growth
  • CUE N/A
  • NEON N/A
  • 52 Week Low
  • CUE $0.54
  • NEON $3.05
  • 52 Week High
  • CUE $1.99
  • NEON $29.90
  • Technical
  • Relative Strength Index (RSI)
  • CUE 38.97
  • NEON 23.45
  • Support Level
  • CUE $0.76
  • NEON $3.13
  • Resistance Level
  • CUE $0.81
  • NEON $3.38
  • Average True Range (ATR)
  • CUE 0.05
  • NEON 0.15
  • MACD
  • CUE -0.01
  • NEON 0.43
  • Stochastic Oscillator
  • CUE 10.92
  • NEON 0.00

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

Share on Social Networks: